Atlas Trials

A Study to Evaluate Safety, Tolerability and Pharmacokinetics of MNKD-201 in Patients With Idiopathic Pulmonary Fibrosis

Clinical trial NCT07344558 · COMPLETED

Trial details

NCT number
NCT07344558
Sponsor
Mannkind Corporation
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Idiopathic Pulmonary Fibrosis (IPF)
Start date
2025-12-22
Primary completion
2026-06-17
Enrollment
27

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.